browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
4c479ab7-9b19-466e-b6ec-97fe8f7a4451
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-21 00:21:09
Income (reported)
$80,000
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

ALSTON & BIRD LLP

Law Firm

Contact
ADAM J. BIEGEL
Phone
+1 202-239-3692
Address
zip:20004, city:WASHINGTON, state:DC, street:THE ATLANTIC BUILDING 950 F STREET, NW
Client

TRAVERE THERAPEUTICS

Prescription pharmaceutical manufacturer of medications.

State
CA
Country
US
Government-entity client
false
Effective date
2016-11-11
Issues lobbied + lobbyists (5)

PHA — Pharmacy

Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs. Most-Favored Nation and International Reference Pricing proposals. PDUFA/regulatory review process.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

Support for H.R.946, Optimizing Research Progress Hope And New Cures Act (ORPHAN Cures Act). Legislation regarding the Orphan Drug Act and rare disease diagnosis, treatment, and care. Legislation regarding kidney disease and in particular rare kidney disease. Legislation regarding newborn screening. H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Support of reauthorization of priority review voucher program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

H.R.1518, New Era of Preventing End-Stage Kidney Disease Act. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs, Medicare and Medicaid.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MED — Medical/Disease Research/Clinical Labs

Legislation regarding clinical research for rare diseases and orphan drug development, and the Accelerated Approval pathway. H.R.1262/S.932, Give Kids a Chance Act to renew PRV program. Related provisions in Pub. L. No. 119-21, One Big Beautiful Bill Act. The Newborn Screening Reauthorization Act. Importance of patient voice in rare kidney disease.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TAX — Taxation/Internal Revenue Code

H.R.1414, Camerons Law, to restore the amount of the Orphan Drug Tax Credit. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding orphan drugs.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.